Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Payables: 2020-2022

Historic Payables for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $380,000.

  • Candel Therapeutics' Payables fell 74.23% to $250,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.7 million, marking a year-over-year decrease of 69.22%. This contributed to the annual value of $380,000 for FY2022, which is 76.10% down from last year.
  • Candel Therapeutics' Payables amounted to $380,000 in FY2022, which was down 76.10% from $1.6 million recorded in FY2021.
  • Candel Therapeutics' Payables' 5-year high stood at $1.6 million during FY2021, with a 5-year trough of $380,000 in FY2022.
  • For the 3-year period, Candel Therapeutics' Payables averaged around $963,667, with its median value being $921,000 (2020).
  • In the last 5 years, Candel Therapeutics' Payables surged by 72.64% in 2021 and then tumbled by 76.10% in 2022.
  • Over the past 3 years, Candel Therapeutics' Payables (Yearly) stood at $921,000 in 2020, then surged by 72.64% to $1.6 million in 2021, then crashed by 76.10% to $380,000 in 2022.